id: x2023_calcium
title: 'Calcium Supplements and Risk of CVD: A Meta-Analysis of Randomized Trials'
authors:
- Huo X
- Clarke R
- Halsey J
- Jackson R
- Lehman A
- Prince R
- Lewis J
- Baron JA
- Kroger H
- Sund R
year: 2023
reference_type: Journal article
keywords:
- CVD
- calcium
- meta-analysis
- randomized
- supplement
- supplements
- trials
hard_claims:
- summary: Calcium supplements alone show no significant excess risk of myocardial
    infarction
  choice: calcium
  evidence_type: Meta-analysis
  effects:
  - outcome: myocardial infarction
    mean: 1.15
    std: 0.16071428571428573
  population: general adult population
  sample_size: 8634
  notes: 7 trials with 219 MI events; no significant excess risk detected for any
    CHD or stroke either
- summary: Calcium plus vitamin D supplementation shows no significant excess CVD
    risk
  choice: calcium
  evidence_type: Meta-analysis
  effects:
  - outcome: myocardial infarction
    mean: 1.09
    std: 0.07653061224489797
  population: general adult population
  sample_size: 46804
  notes: 6 trials with 854 MI events; studies lacked power to detect small increases
    in risk (>0.3-0.5% per year)
soft_claims: []
journal: Curr Dev Nutr
volume: '7'
issue: '3'
pages: '100046'
doi: ''
pmid: ''
url: https://pmc.ncbi.nlm.nih.gov/articles/PMC10111600/
summary: Meta-analysis of 11 randomized, placebo-controlled trials (>55,000 participants)
  examining calcium supplements and CVD risk. Neither calcium alone (7 trials, n=8,634)
  nor calcium plus vitamin D (6 trials, n=46,804) showed significant excess risk for
  MI, CHD, or stroke. Studies could only exclude CVD risk increases greater than 0.3-0.5%
  per year.
